| Authors: |
Desai A; Division of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA., Gainor JF; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Hegde A; Department of Hematology and Oncology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Schram AM; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Curigliano G; Department of Oncology and Hemato- Oncology, University of Milan and European Institute of Oncology, IRCCS, Milan, Italy., Pal S; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Liu SV; Department of Developmental Therapeutics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Halmos B; Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, The Bronx, NY, USA., Groisberg R; Department of Melanoma/Sarcoma Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Dragovich T; Department of Hematology/Oncology, MD Anderson Banner Cancer Center, Gilbert, AZ, USA., Matrana M; Precision Cancer Therapies (Phase I) Research Program, Experimental Therapeutics, Ochsner, New Orleans, LA, USA., Agarwal N; Division of Oncology, Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Chawla S; Sarcoma Oncology Center, Santa Monia, CA, USA., Kato S; Center for Personalized Cancer Therapy, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Morgan G; Department of Oncology, Skåne University Hospital, Lund, Sweden., Kasi PM; Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Medicine, University of Iowa, Iowa City, IA, USA., Solomon B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Loong HH; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China., Park H; Division of Oncology, Department of Medicine, Washington University in St. Louis, St Louis, MO, USA., Choueiri TK; Department of Medical Oncology, Dana- Farber Cancer Institute, Boston, MA, USA., Subbiah IM; Department of Palliative, Rehabilitation & Integrative Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pemmaraju N; Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Subbiah V; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. vsubbiah@mdanderson.org.; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. vsubbiah@mdanderson.org.; MD Anderson Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. vsubbiah@mdanderson.org. |
